Monoclonal antibodies (mAbs) — preparations of a type of antibody designed to bind to a single target — have shown promise in the fight against cancer and autoimmune diseases. They also may play a role in future battles against emerging infectious disease outbreaks. A new article outlines the potential uses for mAbs as treatments for infectious diseases, as prevention for protecting at-risk individuals, and slowing disease outbreaks.